Skip to main content

Table 2 Clinical characteristics, use of therapeutic procedures and hospital outcomes after matching by age and myocardial infarction type (ICD 10) for men and women hospitalized with STEMI according to the presence of T2DM

From: Are there sex differences in the effect of type 2 diabetes in the incidence and outcomes of myocardial infarction? A matched-pair analysis using hospital discharge data

 

Men

Women

No T2DM

T2DM

p-value

No T2DM

T2DM

p-value

STEMI involving left main coronary artery, n (%)

92 (0.59)

92 (0.59)

NA

28 (0.40)

28 (0.40)

NA

STEMI involving left anterior descending coronary artery, n (%)

1859 (11.99)

1859 (11.99)

NA

689 (9.85)

689 (9.85)

NA

STEMI involving other coronary artery of anterior wall, n (%)

3722 (24.01)

3722 (24.01)

 

1796 (25.68)

1796 (25.68)

NA

STEMI involving right coronary artery, n (%)

2163 (13.95)

2163 (13.95)

NA

771 (11.02)

771 (11.02)

NA

STEMI involving other coronary artery of inferior wall, n (%)

4204 (27.12)

4204 (27.12)

NA

1729 (24.72)

1729 (24.72)

NA

STEMI involving left circumflex coronary artery, n (%)

293 (1.89)

293 (1.89)

NA

91 (1.30)

91 (1.30)

NA

STEMI involving other sites, n (%)

843 (5.44)

843 (5.44)

NA

386 (5.52)

386 (5.52)

NA

STEMI of unspecified site, n (%)

2327 (15.01)

2327 (15.01)

NA

1504 (21.50)

1504 (21.50)

NA

Age, mean (SD)

67.33 (11.88)

67.33 (11.88)

NA

75.87 (11.43)

75.87 (11.43)

NA

CCI, mean (SD)

0.45 (0.74)

0.61 (0.56)

< 0.001

0.55 (0.47)

0.72 (0.65)

< 0.001

Obesity, n (%)

1384 (8.93)

2422 (15.62)

< 0.001

760 (10.87)

1242 (17.76)

< 0.001

Hypertension, n (%)

6516 (42.03)

8687 (56.03)

< 0.001

3566 (50.99)

4226 (60.42)

< 0.001

Lipid metabolism disorders, n (%)

6198 (39.98)

8922 (57.55)

< 0.001

2910 (41.61)

3927 (56.15)

< 0.001

Renal disease, n (%)

1019 (6.57)

1883 (12.15)

< 0.001

653 (9.34)

1155 (16.51)

< 0.001

Atrial fibrillation, n (%)

1857 (11.98)

1841 (11.88)

0.779

1369 (19.57)

1212 (17.33)

0.001

Congestive heart failure, n (%)

2087 (13.46)

2648 (17.08)

< 0.001

1424 (20.36)

1870 (26.74)

< 0.001

Peripheral vascular disease, n (%)

722 (4.66)

1166 (7.52)

< 0.001

186 (2.66)

310 (4.43)

< 0.001

Cerebrovascular disease, n (%)

387 (2.50)

621 (4.01)

< 0.001

277 (3.96)

376 (5.38)

< 0.001

Dementia, n (%)

170 (1.10)

215 (1.39)

0.021

272 (3.89)

334 (4.78)

0.010

Mechanical ventilation, n (%)

1075 (6.93)

1093 (7.05)

0.689

429 (6.13)

487 (6.96)

0.047

CABG, n (%)

180 (1.16)

235 (1.52)

0.007

44 (0.63)

52 (0.74)

0.413

PCI, n (%)

9629 (62.11)

9406 (60.67)

0.009

3384 (48.38)

3257 (46.57)

0.032

LOHS, median (IQR)

5.00 (5.00)

5.00 (5.00)

0.650

5.00 (5.00)

5.00 (5.00)

0.921

In-hospital mortality, n (%)

1184 (7.64)

1214 (7.83)

0.524

944 (13.50)

1091 (15.60)

< 0.001

  1. STEMI ST-elevation myocardial infarction, CCI Charlson comorbidity index, CABG coronary artery bypass graft, PCI percutaneous coronary intervention, LOHS length of hospital stay, NA not applicable
  2. The P values for the differences between patients with T2DM and No T2DM were calculated using Student’s t-test, or Mann–Whitney test or chi-square tests